MariMed, Inc. Reports 2018 Fourth Quarter and Year End Results; Strong Revenue and EBITDA Growth Fourth Quarter 2018: 118% Year-Over-Year Revenue GrowthFiscal 2018: 95% Revenue Year-Over-Year Growth; Adjusted EBITDA up 53%Strategic Investments Position MariMed for Dynamic Growth in Cannabis and...